|Articles|September 2, 2020
AstraZeneca COVID-19 vaccine to US Phase 3 trial
Author(s)Lindsey Carr, Editor
According a press release and a recent article from Drug Topics, AstraZeneca’s investigational vaccine candidate AZD12222 expanded into a phase 3 clinical trial.
Advertisement
The trial is funded by the Biomedical Advanced Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID).
Up to 30,000 adults aged 18 years or older will be enrolled to assess the safety and immunogenicity of AZD1222, which was co-invented by the University of Oxford and Vaccitech.
For more information, read the full article from
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Study details cesarean use in life-limiting fetal diagnosis cases
2
20-year data show shifting causes of pregnancy-related death
3
FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues
4
Early-onset severe HDP carries highest recurrence risk, study finds
5